Literature DB >> 18342879

Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography.

Edward P Havranek1, Caroline D B Emsermann, Desiree N Froshaug, Frederick A Masoudi, Mori J Krantz, Rebecca Hanratty, Raymond O Estacio, L Miriam Dickinson, John F Steiner.   

Abstract

BACKGROUND: Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy in current use were defined using autopsy results or echocardiography; criteria defined using mortality might be more clinically meaningful.
METHODS: Using data from Third National Health and Nutrition Examination Survey (NHANES III), we selected electrocardiographic measures that best differentiated those surviving at 5 years from those who did not. We identified voltage thresholds using regression techniques and then compared survival for subjects above and below the thresholds.
RESULTS: Cornell voltage, Cornell product, and Novacode estimate of left ventricular mass index were discriminative for mortality and had identifiable thresholds present in their relationships with mortality. Independent of systolic blood pressure, there were significant associations with 5-year mortality for Novacode index above threshold; hazard ratios were 1.58 for women and 1.27 for men, and for 5-year cardiovascular mortality were 1.78 for women and 2.34 for men.
CONCLUSIONS: Electrocardiographic criteria for left ventricular hypertrophy validated against mortality might be clinically useful.

Entities:  

Mesh:

Year:  2008        PMID: 18342879      PMCID: PMC2556300          DOI: 10.1016/j.jelectrocard.2007.11.006

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  31 in total

1.  Increased left ventricular mass in patients with lateral low-voltage electrocardiograms.

Authors:  S Velury; D H Spodick
Journal:  Am J Cardiol       Date:  1992-03-01       Impact factor: 2.778

2.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

3.  Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the First National Health and Nutrition Examination Survey.

Authors:  P M Rautaharju; A Z LaCroix; D D Savage; S G Haynes; J H Madans; H K Wolf; W Hadden; J Keller; J Cornoni-Huntley
Journal:  Am J Cardiol       Date:  1988-07-01       Impact factor: 2.778

4.  Race- and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans.

Authors:  P M Rautaharju; L P Park; J S Gottdiener; D Siscovick; R Boineau; V Smith; N R Powe
Journal:  J Electrocardiol       Date:  2000-07       Impact factor: 1.438

5.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

6.  Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence.

Authors:  D K Lee; P R Marantz; R B Devereux; P Kligfield; M H Alderman
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

7.  Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.

Authors:  P N Casale; R B Devereux; P Kligfield; R R Eisenberg; D H Miller; B S Chaudhary; M C Phillips
Journal:  J Am Coll Cardiol       Date:  1985-09       Impact factor: 24.094

8.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; D D Savage; R J Garrison; K M Anderson; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-04-15       Impact factor: 2.778

9.  How reliable is the electrocardiogram in detecting left ventricular hypertrophy in hypertension?

Authors:  S G Vijan; G Manning; M W Millar-Craig
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

10.  Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.

Authors:  P N Casale; R B Devereux; D R Alonso; E Campo; P Kligfield
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

View more
  13 in total

1.  Reply to: Should physicians aggressively treat pre-hypertension?

Authors:  Edward P Havranek
Journal:  Am J Med       Date:  2009-05-01       Impact factor: 4.965

2.  Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Michael E Ernst; Barry R Davis; Elsayed Z Soliman; Ronald J Prineas; Peter M Okin; Alokananda Ghosh; William C Cushman; Paula T Einhorn; Suzanne Oparil; Richard H Grimm
Journal:  J Am Soc Hypertens       Date:  2016-11-09

3.  Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD.

Authors:  Rajat Deo; Haochang Shou; Elsayed Z Soliman; Wei Yang; Joshua M Arkin; Xiaoming Zhang; Raymond R Townsend; Alan S Go; Michael G Shlipak; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2015-07-09       Impact factor: 10.121

4.  Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity.

Authors:  Edward P Havranek; Desiree B Froshaug; Caroline D B Emserman; Rebecca Hanratty; Mori J Krantz; Frederick A Masoudi; L Miriam Dickinson; John F Steiner
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

5.  Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population.

Authors:  Rajat Deo; Faye L Norby; Ronit Katz; Nona Sotoodehnia; Selcuk Adabag; Christopher R DeFilippi; Bryan Kestenbaum; Lin Y Chen; Susan R Heckbert; Aaron R Folsom; Richard A Kronmal; Suma Konety; Kristen K Patton; David Siscovick; Michael G Shlipak; Alvaro Alonso
Journal:  Circulation       Date:  2016-08-19       Impact factor: 29.690

6.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Authors:  Elsayed Z Soliman; Robert P Byington; J Thomas Bigger; Gregory Evans; Peter M Okin; David C Goff; Haiying Chen
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

7.  Electrocardiographic deep terminal negativity of the P wave in V1 and risk of mortality: the National Health and Nutrition Examination Survey III.

Authors:  Larisa G Tereshchenko; Amit J Shah; Yabing Li; Elsayed Z Soliman
Journal:  J Cardiovasc Electrophysiol       Date:  2014-06-11

Review 8.  Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.

Authors:  Francesca Miceli; Vivianne Presta; Barbara Citoni; Flaminia Canichella; Ilaria Figliuzzi; Andrea Ferrucci; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-06       Impact factor: 3.738

9.  Fractal Analysis of Myocardial Trabeculations in 2547 Study Participants: Multi-Ethnic Study of Atherosclerosis.

Authors:  Gabriella Captur; Filip Zemrak; Vivek Muthurangu; Steffen E Petersen; Chunming Li; Paul Bassett; Nadine Kawel-Boehm; William J McKenna; Perry M Elliott; João A C Lima; David A Bluemke; James C Moon
Journal:  Radiology       Date:  2015-06-10       Impact factor: 11.105

10.  Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging.

Authors:  Ljuba Bacharova; Haiying Chen; E Harvey Estes; Anton Mateasik; David A Bluemke; Joao A C Lima; Gregory L Burke; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2014-11-29       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.